カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の細胞培養市場2023-2030：製品別（消耗品、器具）、用途別（バイオ医薬品製造、診断、細胞・遺伝子治療）、地域別

【英語タイトル】Cell Culture Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Application (Biopharmaceutical Production, Diagnostics, Cell & Gene Therapy), By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV009）・商品コード：GRV23NOV009
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：150
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：バイオ
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

細胞培養市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の細胞培養市場規模は2030年までに390.9億米ドルに達し、2023年から2030年までの年平均成長率は11.32%で推移すると予測されています。新規の三次元細胞培養技術や、バイオ医薬品開発、ワクチン生産におけるニーズの高まり、先端治療医薬品に対する世界的な需要の高まりが、予測期間中の市場を牽引すると見られています。COVID-19の大流行により、特に新規mRNAワクチンやDNAワクチンの分野でワクチン開発活動が活発化しています。大規模なワクチン生産は、細胞培養技術を用いて生産されるベクターに対する高い需要を生み出します。例えば、2023年2月、SK Bioscienceは、同社初の細胞培養ベースの4価インフルエンザワクチンであるSKYCellfluが、南米でInstituto de Salud Publica de Chile（公衆衛生研究所、ISP）から正式に認可されたと発表しました。

さらに、ワクチン開発には、細胞ベースのアッセイを使用するいくつかの発現解析、品質管理、安全性試験手順が必要です。その結果、このような用途での細胞培養製品の使用は、近年高い需要を目の当たりにしています。さらに、感染症の発生率の増加、疾病発生の予防への関心の高まり、ワクチン技術への研究開発投資の高さにより、ワクチン生産が牽引力を増し、市場の成長を後押しすると予測されています。バイオ医薬品の分野では、哺乳類細胞の培養が可能になったことで、研究者は複雑なタンパク質ベースの医薬品を大量に生産できるようになりました。

このことは、バイオ医薬品産業における効率向上、コスト削減、品質管理の改善につながりました。さらに、高収率細胞株の上市と培養条件の最適化が、生産性とスケーラビリティの向上に寄与しています。例えば、2023年6月、Matica Bio社はBIO International ConventionでMatiMax細胞株を発表しました。さらに、複数の企業が市場拡大などの戦略的イニシアチブに取り組んでおり、これが市場成長の要因となっています。例えば、2021年3月、Thermo Fisher Scientific, Inc.は、2022年までの設備投資に6億米ドルを投資する拡大計画を発表しました。スコットランド、フロリダ、ニューヨークにある同社の細胞培養培地およびプロセス液拠点は、ギブコの細胞培養培地、プロセス液、サプリメントの生産能力を増強。このような開発は、予測期間中の市場成長を促進すると期待されています。

細胞培養市場レポートハイライト

- モノクローナル抗体、ワクチン、細胞・遺伝子治療薬などの先端バイオ医薬品を生産するための製薬・バイオ医薬品企業の研究開発費の増加により、消耗品製品セグメントが2022年に57.44%の最大シェアを占めました。

- バイオ医薬品生産分野は2022年に32.15%の最大シェアを占めました。バイオテクノロジー分野の拡大が予想され、予測期間中に細胞培養用品と機器の需要を促進しました。

- 北米が2022年に35.90%のシェアで市場を独占しました。この大きなシェアは、同地域の製薬・バイオテクノロジー部門が確立されていること、および米国で技術的に高度なソリューションの採用が進んでいることに起因しています。さらに、同地域では複数の大学による大規模な細胞治療研究が行われているため、細胞培養技術の市場も大きくなっています。

- アジア太平洋地域は、細胞療法や遺伝子療法に対する意識の高まり、再生医療やがん免疫療法などの科学技術や新たな治療法の急速な採用により、予測期間中に最も速いCAGR 13.79%で拡大すると予測されています。

第1章 調査方法・範囲
第2章 エグゼクティブサマリー
第3章 市場変数・傾向・範囲
第4章 世界の細胞培養市場：製品別ビジネス分析
第5章 世界の細胞培養市場：用途別ビジネス分析
第6章 世界の細胞培養市場：地域別ビジネス分析
第7章 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Product Segment
1.1.1.2. Application Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objective
1.4.1. Objective 1
1.4.2. Objective2
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis:
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Expansion in the scope of cell culture technology
3.2.1.2. Rising demand for biopharmaceuticals, artificial organs, & vaccine production
3.2.1.3. Growth in demand for serum-free, specialty, and customized media
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent process control in cell culture techniques
3.2.2.2. Scalability issues with culturing methods
3.2.2.3. Ethical concerns regarding use of animals
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Cell Culture Market: Product Movement Analysis
4.2. Consumables
4.2.1. Global Consumables Market, 2018 – 2030 (USD Million)
4.2.2. Media
4.2.2.1. Global media market, 2018 – 2030 (USD million)
4.2.2.2. Serum-free media
4.2.2.2.1. Global serum-free media market, 2018 – 2030 (USD million)
4.2.2.2.2. CHO media
4.2.2.2.2.1. Global CHO media market, 2018 – 2030 (USD million)
4.2.2.2.3. BHK medium
4.2.2.2.3.1. Global BHK medium market, 2018 – 2030 (USD million)
4.2.2.2.4. Vero medium
4.2.2.2.4.1. Global Vero medium market, 2018 – 2030 (USD million)
4.2.2.2.5. HEK 293 Media
4.2.2.2.5.1. Global HEK 293 media market, 2018 – 2030 (USD million)
4.2.2.2.6. Other serum-free media
4.2.2.2.6.1. Global other serum-free media market, 2018 – 2030 (USD million)
4.2.2.3. Classical media
4.2.2.3.1. Global classical media market, 2018 – 2030 (USD million)
4.2.2.4. Stem cell culture media
4.2.2.4.1. Global stem cell culture media market, 2018 – 2030 (USD million)
4.2.2.5. Specialty media
4.2.2.5.1. Global specialty media market, 2018 – 2030 (USD million)
4.2.2.6. Chemically defined media
4.2.2.6.1. Global chemically defined media market, 2018 – 2030 (USD million)
4.2.2.7. Other cell culture media
4.2.2.7.1. Global other cell culture media market, 2018 – 2030 (USD million)
4.2.3. Sera
4.2.3.1. Global sera market, 2018 – 2030 (USD million)
4.2.3.2. Fetal bovine serum
4.2.3.2.1. Global fetal bovine serum market, 2018 – 2030 (USD million)
4.2.3.3. Others
4.2.3.3.1. Global others market, 2018 – 2030 (USD million)
4.2.4. Reagents
4.2.4.1. Global reagents market, 2018 – 2030 (USD million)
4.2.4.2. Albumin
4.2.4.2.1. Global albumin market, 2018 – 2030 (USD million)
4.2.4.3. Others
4.2.4.3.1. Global others market, 2018 – 2030 (USD million)
4.3. Instruments
4.3.1. Global instruments market, 2018 – 2030 (USD million)
4.3.2. Culture systems
4.3.2.1. Global culture systems market, 2018 – 2030 (USD million)
4.3.3. Incubators
4.3.3.1. Global incubators market, 2018 – 2030 (USD million)
4.3.4. Centrifuges
4.3.4.1. Global centrifuges market, 2018 – 2030 (USD million)
4.3.5. Cryostorage equipment
4.3.5.1. Global cryostorage equipment market, 2018 – 2030 (USD million)
4.3.6. Biosafety equipment
4.3.6.1. Global biosafety equipment market, 2018 – 2030 (USD million)
4.3.7. Pipetting instruments
4.3.7.1. Global pipetting instruments market, 2018 – 2030 (USD million)
Chapter 5. Application Business Analysis
5.1. Cell Culture Market: Application Movement Analysis
5.2. Biopharmaceutical Production
5.2.1. Global Biopharmaceutical Production Market, 2018 – 2030 (USD Million)
5.2.2. Monoclonal antibodies
5.2.2.1. Monoclonal antibodies market, 2018 – 2030 (USD million)
5.2.3. Vaccines production
5.2.3.1. Global vaccines production market, 2018 – 2030 (USD million)
5.2.4. Other therapeutic proteins
5.2.4.1. Global other therapeutic proteins market, 2018 – 2030 (USD million)
5.3. Drug Development
5.3.1. Global drug development market, 2018 – 2030 (USD Million)
5.4. Diagnostics
5.4.1. Global diagnostics market, 2018 – 2030 (USD Million)
5.5. Tissue Culture & Engineering
5.5.1. Global tissue culture & engineering, 2018 – 2030 (USD Million)
5.6. Cell & Gene Therapy
5.6.1. Global cell and gene therapy market, 2018 – 2030 (USD million)
5.7. Toxicity Testing
5.7.1. Global toxicity testing market, 2018 – 2030 (USD million)
5.8. Other Applications
5.8.1. Global other applications market, 2018 – 2030 (USD million)
Chapter 6. Regional Business Analysis
6.1. Cell Culture Market Share By Region, 2022 & 2030
6.2. North America
6.2.1. North America Cell Culture Market, 2018 – 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. Key Country Dynamics
6.2.2.2. Competitive Scenario
6.2.2.3. Regulatory Framework
6.2.2.4. U.S. Cell Culture Market, 2018 – 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Key Country Dynamics
6.2.3.2. Competitive Scenario
6.2.3.3. Regulatory Framework
6.2.3.4. Canada Cell Culture Market, 2018 – 2030 (USD Million)
6.3. Europe
6.3.1. Europe Cell Culture Market, 2018 – 2030 (USD Million)
6.3.2. UK
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. UK Cell Culture Market, 2018 – 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Germany Cell Culture Market, 2018 – 2030 (USD Million)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. France Cell Culture Market, 2018 – 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Competitive Scenario
6.3.5.3. Regulatory Framework
6.3.5.4. Italy Cell Culture Market, 2018 – 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Competitive Scenario
6.3.6.3. Regulatory Framework
6.3.6.4. Spain Cell Culture Market, 2018 – 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Competitive Scenario
6.3.7.3. Regulatory Framework
6.3.7.4. Denmark Cell Culture Market, 2018 – 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Competitive Scenario
6.3.8.3. Regulatory Framework
6.3.8.4. Sweden Cell Culture Market, 2018 – 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Competitive Scenario
6.3.9.3. Regulatory Framework
6.3.9.4. Norway Cell Culture Market, 2018 – 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Cell Culture Market, 2018 – 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. Japan Cell Culture Market, 2018 – 2030 (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. China Cell Culture Market, 2018 – 2030 (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. India Cell Culture Market, 2018 – 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Australia Cell Culture Market, 2018 – 2030 (USD Million)
6.4.6. Thailand
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Thailand Cell Culture Market, 2018 – 2030 (USD Million)
6.4.7. South Korea
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. South Korea Cell Culture Market, 2018 – 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Cell Culture Market, 2018 – 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Brazil Cell Culture Market, 2018 – 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Mexico Cell Culture Market, 2018 – 2030 (USD Million)
6.5.4. Argentina
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Argentina Cell Culture Market, 2018 – 2030 (USD Million)
6.6. MEA
6.6.1. MEA Cell Culture Market, 2018 – 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. South Africa Cell Culture Market, 2018 – 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Saudi Arabia Cell Culture Market, 2018 – 2030 (USD Million)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. UAE Cell Culture Market, 2018 – 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Kuwait Cell Culture Market, 2018 – 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.3. Company Market Share Analysis, 2022
7.4. Company Profiles/Listing
7.4.1. Sartorius AG
7.4.1.1. Overview
7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Danaher
7.4.2.1. Overview
7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Merck KGaA
7.4.3.1. Overview
7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Thermo Fisher Scientific, Inc.
7.4.4.1. Overview
7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Corning Inc.
7.4.5.1. Overview
7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. Avantor Inc.
7.4.6.1. Overview
7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. BD
7.4.7.1. Overview
7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Eppendorf SE
7.4.8.1. Overview
7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Bio-Techne
7.4.9.1. Overview
7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.9.3. Product Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. PromoCell GmbH
7.4.10.1. Overview
7.4.10.2. Product Benchmarking
7.4.10.3. Strategic Initiatives

List of Tables

Table 1 Global cell culture market, by region, 2018 - 2030 (USD Million)
Table 2 Global cell culture market, by product, 2018 - 2030 (USD Million)
Table 3 Global cell culture market, by application, 2018 - 2030 (USD Million)
Table 4 North America cell culture market, by product, 2018 - 2030 (USD Million)
Table 5 North America cell culture market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. cell culture market, by product, 2018 - 2030 (USD Million)
Table 7 U.S. cell culture market, by application, 2018 - 2030 (USD Million)
Table 8 Canada cell culture market, by product, 2018 - 2030 (USD Million)
Table 9 Canada cell culture market, by application, 2018 - 2030 (USD Million)
Table 10 Europe cell culture market, by product, 2018 - 2030 (USD Million)
Table 11 Europe cell culture market, by application, 2018 - 2030 (USD Million)
Table 12 UK cell culture market, by product, 2018 - 2030 (USD Million)
Table 13 UK cell culture market, by application, 2018 - 2030 (USD Million)
Table 14 Germany cell culture market, by product, 2018 - 2030 (USD Million)
Table 15 Germany cell culture market, by application, 2018 - 2030 (USD Million)
Table 16 France cell culture market, by product, 2018 - 2030 (USD Million)
Table 17 France cell culture market, by application, 2018 - 2030 (USD Million)
Table 18 Italy cell culture market, by product, 2018 - 2030 (USD Million)
Table 19 Italy cell culture market, by application, 2018 - 2030 (USD Million)
Table 20 Spain cell culture market, by product, 2018 - 2030 (USD Million)
Table 21 Spain cell culture market, by application, 2018 - 2030 (USD Million)
Table 22 Denmark cell culture market, by product, 2018 - 2030 (USD Million)
Table 23 Denmark cell culture market, by application, 2018 - 2030 (USD Million)
Table 24 Sweden cell culture market, by product, 2018 - 2030 (USD Million)
Table 25 Sweden cell culture market, by application, 2018 - 2030 (USD Million)
Table 26 Norway cell culture market, by product, 2018 - 2030 (USD Million)
Table 27 Norway cell culture market, by application, 2018 - 2030 (USD Million)
Table 28 Asia Pacific cell culture market, by product, 2018 - 2030 (USD Million)
Table 29 Asia Pacific cell culture market, by application, 2018 - 2030 (USD Millon)
Table 30 Japan cell culture market, by product, 2018 - 2030 (USD Million)
Table 31 Japan cell culture market, by application, 2018 - 2030 (USD Million)
Table 32 China cell culture market, by product, 2018 - 2030 (USD Million)
Table 33 China cell culture market, by application, 2018 - 2030 (USD Million)
Table 34 India cell culture market, by product, 2018 - 2030 (USD Million)
Table 35 India cell culture market, by application, 2018 - 2030 (USD Million)
Table 36 Australia cell culture market, by product, 2018 - 2030 (USD Million)
Table 37 Australia cell culture market, by application, 2018 - 2030 (USD Million)
Table 38 South Korea cell culture market, by product, 2018 - 2030 (USD Million)
Table 39 South Korea cell culture market, by application, 2018 - 2030 (USD Million)
Table 40 Thailand cell culture market, by product, 2018 - 2030 (USD Million)
Table 41 Thailand cell culture market, by application, 2018 - 2030 (USD Million)
Table 42 Latin America cell culture market, by product, 2018 - 2030 (USD Million)
Table 43 Latin America cell culture market, by application, 2018 - 2030 (USD Million)
Table 44 Brazil cell culture market, by product, 2018 - 2030 (USD Million)
Table 45 Brazil cell culture market, by application, 2018 - 2030 (USD Million)
Table 46 Mexico cell culture market, by product, 2018 - 2030 (USD Million)
Table 47 Mexico cell culture market, by application, 2018 - 2030 (USD Million)
Table 48 Argentina cell culture market, by product, 2018 - 2030 (USD Million)
Table 49 Argentina cell culture market, by application, 2018 - 2030 (USD Million)
Table 50 Middle East & Africa cell culture market, by product, 2018 - 2030 (USD Million)
Table 51 Middle East & Africa cell culture market, by application, 2018 - 2030 (USD Million)
Table 52 South Africa cell culture market, by product, 2018 - 2030 (USD Million)
Table 53 South Africa cell culture market, by application, 2018 - 2030 (USD Million)
Table 54 Saudi Arabia cell culture market, by product, 2018 - 2030 (USD Million)
Table 55 Saudi Arabia cell culture market, by application, 2018 - 2030 (USD Million)
Table 56 UAE cell culture market, by product, 2018 - 2030 (USD Million)
Table 57 UAE cell culture market, by application, 2018 - 2030 (USD Million)
Table 58 Kuwait cell culture market, by product, 2018 - 2030 (USD Million)
Table 59 Kuwait cell culture market, by application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Cell culture market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot
Fig. 14 Competitive landscape snapshot
Fig. 15 Life science tools market value, 2022 (USD billion)
Fig. 16 Market trends & outlook
Fig. 17 Number of biologics approved by the U.S. FDA each year from 2015 to 2022
Fig. 18 PESTEL analysis
Fig. 19 Porter’s five forces analysis
Fig. 20 Cell culture market: Product outlook & key takeaways
Fig. 21 Cell culture market: Product movement analysis
Fig. 22 Global consumables market, 2018 - 2030 (USD Million)
Fig. 23 Global media market, 2018 - 2030 (USD Million)
Fig. 24 Global serum-free media market, 2018 - 2030 (USD Million)
Fig. 25 Global CHO media market, 2018 - 2030 (USD Million)
Fig. 26 Global BHK medium market, 2018 - 2030 (USD Million)
Fig. 27 Global Vero medium market, 2018 - 2030 (USD Million)
Fig. 28 Global HEK 293 media market, 2018 - 2030 (USD Million)
Fig. 29 Global other serum-free media market, 2018 - 2030 (USD Million)
Fig. 30 Global classical media market, 2018 - 2030 (USD Million)
Fig. 31 Global stem cell culture media market, 2018 - 2030 (USD Million)
Fig. 32 Global specialty media market, 2018 - 2030 (USD Million)
Fig. 33 Global chemically defined media market, 2018 - 2030 (USD Million)
Fig. 34 Global other cell culture media market, 2018 - 2030 (USD Million)
Fig. 35 Global sera market, 2018 - 2030 (USD Million)
Fig. 36 Global fetal bovine serum market, 2018 - 2030 (USD Million)
Fig. 37 Global others market, 2018 - 2030 (USD Million)
Fig. 38 Global reagents market, 2018 - 2030 (USD Million)
Fig. 39 Global albumin market, 2018 - 2030 (USD Million)
Fig. 40 Global others market, 2018 - 2030 (USD Million)
Fig. 41 Global instruments market, 2018 - 2030 (USD Million)
Fig. 42 Global culture systems market, 2018 - 2030 (USD Million)
Fig. 43 Global incubators market, 2018 - 2030 (USD Million)
Fig. 44 Global centrifuges market, 2018 - 2030 (USD Million)
Fig. 45 Global cryostorage equipment market, 2018 - 2030 (USD Million)
Fig. 46 Global biosafety equipment market, 2018 - 2030 (USD Million)
Fig. 47 Global pipetting instruments market, 2018 - 2030 (USD Million)
Fig. 48 Cell culture market: Application outlook key takeaways
Fig. 49 Cell culture market: Application movement analysis
Fig. 50 Global biopharmaceutical production market, 2018 - 2030 (USD Million)
Fig. 51 Global monoclonal antibodies market, 2018 - 2030 (USD Million)
Fig. 52 Global vaccines production market, 2018 - 2030 (USD Million)
Fig. 53 Global other therapeutic proteins market, 2018 - 2030 (USD Million)
Fig. 54 Global drug development market, 2018 - 2030 (USD Million)
Fig. 55 Global diagnostics market, 2018 - 2030 (USD Million)
Fig. 56 Global tissue culture & engineering market, 2018 - 2030 (USD Million)
Fig. 57 Global cell and gene therapy market, 2018 - 2030 (USD Million)
Fig. 58 Global toxicity testing market, 2018 - 2030 (USD Million)
Fig. 59 Global other applications market, 2018 - 2030 (USD Million)
Fig. 60 Regional outlook
Fig. 61 Regional marketplace: Key takeaways
Fig. 62 North America cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 U.S. cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Canada cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Europe cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Germany cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 UK cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 France cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Italy cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Spain cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Denmark cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Sweden cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Norway cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Asia Pacific cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Japan cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 China cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 India cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 Australia cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 Thailand cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 South Korea cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Latin America cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 Brazil cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 Key country dynamics
Fig. 101 Mexico cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 102 Key country dynamics
Fig. 103 Argentina cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 MEA cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Key country dynamics
Fig. 106 South Africa cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 Saudi Arabia cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 109 Key country dynamics
Fig. 110 UAE cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 111 Key country dynamics
Fig. 112 Kuwait cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 113 Market participant categorization
Fig. 114 Global cell culture market share analysis, 2022
Fig. 115 Strategic framework

★調査レポート[世界の細胞培養市場2023-2030：製品別（消耗品、器具）、用途別（バイオ医薬品製造、診断、細胞・遺伝子治療）、地域別] (コード：GRV23NOV009)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の細胞培養市場2023-2030：製品別（消耗品、器具）、用途別（バイオ医薬品製造、診断、細胞・遺伝子治療）、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の生物学的安全性試験製品・サービス市場2023-2030：製品別（試薬・キット、サービス）、用途別（ワクチン・治療薬、遺伝子治療）、試験タイプ別、地域別
  • 世界の再生医療市場2023-2030：製品別（細胞免疫療法、遺伝子治療）、治療区分別、地域別
  • 世界の先進治療薬CDMO市場2023-2030：製品別（遺伝子治療、細胞治療、組織工学）、フェーズ別、疾患別、地域別
  • 世界の血友病市場2023-2030：種類別（血友病A）、治療種類別（オンデマンド）、治療法別（遺伝子治療、モノクローナル抗体）、流通チャネル別、地域別
  • 世界の無血清培地（SFM）市場2023-2030：製品別（CHO培地、HEK 293培地、BHK培地、Vero培地、幹細胞培地、その他無血清培地）、用途別（バイオ医薬品製造、モノクローナル抗体、ワクチン製造、組織工学＆再生医療、その他治療用タンパク質）、種類別（液体培地、半固体培地、固体培地）、エンドユーザー別（製薬＆バイオテクノロジー企業、研究＆学術機関、その他エンドユーザー）、地域別
  • 世界の高分子バイオ分析技術市場2024-2030：製品・サービス別、用途別（生物製剤、細胞＆遺伝子治療）、地域別
  • 世界の先進治療薬（ATMP）市場2023-2030：治療タイプ別（細胞治療、遺伝子治療、組織工学製品）、地域別（北米、ヨーロッパ、アジア太平洋、その他地域）

    • ◆H&Iグローバルリサーチのお客様（例）◆